FDAnews
www.fdanews.com/articles/97773-american-stock-exchange-accepts-callisto-pharamceuticals-rsquo-plan-of-compliance-and-extension-to-regain-compliance-with-standards

American Stock Exchange Accepts Callisto Pharamceuticals’ Plan of Compliance and Extension to Regain Compliance With Standards

August 29, 2007

Callisto Pharmaceuticals, Inc., a developer of new drug treatments in the fight against cancer and gastrointestinal disorders and diseases, announced that the staff of the American Stock Exchange has reviewed the company’s plan of compliance to meet the AMEX’s continued listing standards and will continue the Company’s listing while the Company seeks to regain compliance with Sections 1003 (a)(i) and 1003 (a)(ii) during the period ending April 3, 2008.
Yahoo Finance